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Abbreviations and definitions  
aa amino acid 
APC adenomatous polyposis coli 
ASCR Academy of Sciences of the Czech Republic 
ATCC American Type Culture Collection 
c/w cells per well 
CBP cyclic AMP response element-binding protein 
cDNA complementary DNA 
CK1 casein kinase 1 
CK2 casein kinase 2 
CRD cysteine-rich domain 
Dhh Desert hedgehog 
DlgA Drosophila disc large tumor suppressor 
DMEM Dulbecco’s modified Eagle’s medium 
DMSO dimethyl sulfoxide 
DNA Deoxyribonucleic Acid 
dNTP deoxynucleoside triphosphates 
DTT Dithiothreitol 
Dvl Dishevelled 
e.g. exempli gratia 
FBS Foetal Bovine Serum 
Frz Frizzled 
GAPDH glyceraldehyde-3-phosphate dehydrogenase 
GSK3 glycogen synthase kinase 3 
HDAC Histone deacetylase 
HEK Human Embryonic Kidney 
HSV-TK herpes simplex virus thymidine kinase 
Ihh Indian hedgehog 
IMG Institute of Molecular Genetics 
IκBs inhibitors of κB 
LRP low-density lipoprotein receptor-related proteins 
MMTV mouse mammary tumor virus 
MQ Milli-Q 
mRNA messenger RNA 
NF-κB nuclear factor kappa B 
NIH The National Institutes of Health resource for stem cell research 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
Pen Strep, PS penicillin streptomycin 
PKA protein kinase A 
PKC protein kinase C 
pNF-κB-luc NF-κB-luc plasmid 
PP1 protein phosphatase 1 
pRL-TK Renilla plasmid 
PSD95 Post synaptic density protein 
pSTF Super TOPFlash plasmid 
Ptch Patched 
RNA Ribonucleic Acid 
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RNases ribonucleases 
RT-PCR reverse transcription-PCR 
SAMP Serine-Alanine-Methionine-Proline 
SCF Skp1-Cul1-F-box-protein 
sFRP-1 secreted frizzled-related protein 1 
Shh Sonic hedgehog 
Smo Smoothened 
STF Super TOP-Flash 
TCF/LEF T-cell-specific transcription factor/lymphoid enhancer-binding factor 1 
TGF-β transforming growth factor beta 
TNF-α tumor necrosis factor α 
TNKS tankyrase 
Trypsin-EDTA trypsin-ethylenediaminetetraacetic acid 
Wg Wingless 
wp well plate 
wt wild type 
zo-1 zonula occludens-1 protein 
β-TrCP β-transducin repeat-containing protein 
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Adherent cell lines:  Cells can be grown in suspension or adherent 
cultures. Adherent cells attach themselves to the 
surface inside the growth flask. 
Cell signaling pathways: Signaling pathways in between cells. 
Conditioned medium: Medium collected from a growing cell line which 
secret biologically active components, and these 
components will affect some cell functions. 
Endogenous luciferase activity:  The luciferase activity inn the cell without activating 
the canonical Wnt signaling pathway with Wnt-3A 
conditioned medium. 
Ligand: Protein that binds to and activates a receptor (e.g. the 
ligand Wnt bind to the receptor Frz). 
Plasmid: A circular molecule of double stranded DNA that can 
be replicated inside the cell independent of the 
chromosomal DNA. A type of vector. 
Primer: A strand of nucleic acid (DNA or RNA) that is 
complementary to a given DNA sequence and serves 
as a starting point for DNA replication by the enzyme 
DNA polymerase. 
Reporter gene: Often simply called reporter. A transfected gene that 
produces a signal (e.g. fluorescence or 
bioluminescence) when expressed. The reporter gene 
is often attached to the regulatory sequence of a gene 
to quantify this expression. 
Stem cell: Unspecialized cells that are capable of self renewing 
through cell division, and they may differentiate into 
a wide range of specialized cells. 
Synergist: An agent (molecule) that increases the effect of 
another. 
Transcription factor: Protein that bind to regulatory units in the genome 
and control the expression of genes. 
Transfection: The process by which exogenous DNA or RNA is 
introduced into cells. 
Vector: A DNA molecule used to transfer exogenous DNA or 
RNA is introduced into cells. 
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Abstract 
 
From an in silico based screening of 10.000 compounds done by Andrew Voronkov 
prior to this master thesis, 256 small molecules have been examined to find 
compounds that acted as synergists or inhibitors by increasing or decreasing the 
binding between the ligand Wnt and the receptor Frizzled in the canonical Wnt 
signaling pathway. A few possible inhibitors and several possible activators were 
found and the structures of the latter were used for analogue development of 226 
compounds which were also examined. 
Compound C1321 was established as the most potent compound, with some 
analogues of compound C1321 showing similar or a somewhat less activating effect. 
 
Compound C1321 was identified to be a synergist of the canonical Wnt signaling 
pathway with a relative activation up to 3500 % compared to controls and no 
activating effect without Wnt-3A present in the medium. This was established using 
the Luciferase Assay System with HEK293 STF cells and Wnt-3A conditioned 
medium or regular cell medium. The results was also confirmed by the Dual-
Luciferase Reporter Assay System with transiently transfected HEK293 wt cells with 
STF and Renilla plasmids, and by Axin2 real-time RT-PCR on HEK293 wt cells. 
The specificity of compound C1321 for the canonical Wnt signaling pathway was 
explored by examination of the effect on the NF-κB signaling pathway and the Sonic 
hedgehog signaling pathway. The Dual-Luciferase Reporter Assay System with 
HEK293 wt cells transiently transfected with Renilla and NF-κB-luc plasmids and 
activated with TNF-α medium showed no activating effect on the NF-κB signaling 
pathway. The Dual-Luciferase Reporter Assay System with Shh-Light2 cells and 
conditioned Shh-medium showed no activating effect on the Shh signaling pathway. 
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1 Introduction 
 
1.1 Stem cell research 
The history of stem cell research started already in the mid 1800s, with the discovery of 
cell propagation and differentiation, due to improved microscopes1. The discovery of cells 
that generate different types of blood cells was done in the early 1900s2, and the Russian 
histologist Alexander Maksimov came up with the term “stem cell” in 1908 at a congress 
of hematologic society in Berlin3. From the 1960s the stem cell research really took form, 
and the first bone marrow transplant on humans was performed in 19684. 
Stem cells are per definition unspecialized cells that are capable of self renewing through 
cell division, and they may differentiate into a wide range of specialized cells5, 6.  
The potential in using stem cells for treatment and cure of many human diseases and 
disorders makes this a promising research field. 
 
1.2 Signaling pathways 
Inside unicellular organisms, metabolic pathways control the cells biological processes. 
Multicellular organisms are dependent on signaling pathways in between cells (cell 
signaling pathways) as well as signaling pathways inside the cells (metabolic pathways).  
Some of the best known signaling pathways with the current overviews and pathway 
diagrams can be found on the internet pages of Cell Signaling Technology7. Four signaling 
pathways that are especially linked to development of the cell is the transforming growth 
factor beta (TGF-β) signaling pathway, the Notch signaling pathway, the Hedgehog 
signaling pathway, and the canonical Wnt signaling pathway. 
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1.3 The Wnt signaling pathway 
Embryo development is a complex process that involves a variety of steps. Only a few 
different signal pathways are responsible for the multifaceted operation of embryo 
development, and the pleiotropic Wnt signaling pathway affects almost all steps; e.g. 
mesoderm induction8, 9, neural induction10, 11, and body axis formation12, 13. 
In mature organisms the Wnt signaling pathway is required for adult tissue maintenance14, 
15, 16. When the pathway is dysfunctional e.g. due to mutations, several human degenerative 
diseases and numerous cancers may occur. Alzheimer17, multiple sclerosis18, polycystic 
kidney disease19, type 2 diabetes20, arthritis21, colon cancer16, lung cancer22 and breast 
cancer23 are some examples. 
The Wnt signaling pathway achieved its name from a gene in mouse (Int-1, discovered in 
198224), and its orthologue in Drosophila (Wg, wingless, discovered in 1987)25, 26, 27. Int-1 
is a proto-oncogene that is activated by integration of mouse mammary tumor virus 
(MMTV) in mammary tumors24. 
Three different evolutionary conserved pathways that are attended with Wnt receptor 
activation exists, the canonical Wnt pathway, the non-canonical planar cell polarity 
pathway, and the non canonical Wnt/Ca2+ pathway28, 29. Of these the first to be explained 
was the canonical Wnt signaling pathway29. 
 
1.3.1 The canonical Wnt signaling pathway 
One of the main players in the canonical Wnt signaling pathway is β-catenin, which 
regulates gene expression by direct interaction with transcription factors. 
β-catenin, Figure 1, is a member of the armadillo family of proteins. The central area of β-
catenin is a super helix of helices, containing 12 repeats of three helices each30. These 
repeats, called “armadillo repeats”, are domains that are specialized for protein-protein 
binding, and β-catenin may therefore bind to a variety of complexes30.  
 
Figure 1 3D-structure of β-catenin31. 
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The canonical Wnt signaling pathway is well described. Figure 2 shows a simplified 
illustration of this pathway.  
 
 
Figure 2 Simplified illustration of the canonical Wnt signaling pathway and some of the components32.  
OFF-state: The destruction complex with the scaffolding proteins Axin and APC and the kinases GSK3 and 
CK1 phosphorylates β-catenin and targets it for β-TrCP, polyubiquitination and proteosomal degradation. 
The transcriptional repressors Groucho and HDAC bind to LEF/TCF and prevent transcription of target 
genes. 
ON-state: The Wnt ligand binds to the receptor Frizzled and the co-receptor LRP. Dvl attach to the cell 
membrane and help aggregation and phosphorylation of LRP by CK1 and GSK-3. This phosphorylation of 
LRP will give Axin a higher affinity for LRP and the destruction complex will not be formed. β-catenin 
enters the nucleus and binds to LEF/TCF to activate transcription of target genes. 
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1.3.2 The canonical Wnt signaling pathway – OFF-State 
 
In un-stimulated cells β-catenin will not enter the nucleus in significant amounts. This is 
mainly due to a destruction complex in the cytoplasm which phosphorylates β-catenin and 
targets it for ubiquitination and degradation33.  
The destruction complex is built up of a variety of different proteins. Some of the main 
components of this complex are the scaffolding proteins Axin and adenomatous polyposis 
coli (APC), and the serine/threonine kinases glycogen synthase kinase 3 (GSK3) and 
casein kinase 1 (CK1) which phosphorylates β-catenin33. These components of the 
destruction complex will be explained briefly later. 
The phosphorylation of β-catenin targets it for a β-transducin repeats-containing protein (β-
TrCP)34, 35, which is a subunit of the Skp1-Cul1-F-box-protein (SCF) E3 ubiquitin ligase36. 
This E3 ubiquitin ligase will contribute to a polyubiquitination that will mark the target 
protein for proteosomal degradation37, 38, 39, 40. 
 
Some of the components of the destruction complex 
The structures of some of the components of the destruction complex will only be 
described briefly. 
The scaffolding protein Axin has the lowest abundance in the cell, and is therefore 
probably the limiting protein in the complex41, 42. 
APC is a large protein. Three areas of the protein are especially important in this context; 
APC is connected to Axin through three series of SAMP (Serine-Alanine-Methionine-
Proline), and β-catenin is bound to APC through three series of a 15 amino acid (aa) 
sequence and seven 20 aa repeats33. APC gets phosphorylated by GSK3 and CK1ε, and 
this increases the affinity for β-catenin33.  
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CK1 is a family of kinases where several of the members have an effect on the canonical 
Wnt pathway, both with and without Wnt. CK1ε is already mentioned to phosphorylate 
APC. CK1α bound to Axin phosphorylates β-catenin, and primes β-catenin for further 
phosphorylation by GSK343. CK1α phosphorylates Ser4544, while GSK3 phosphorylates at 
least Ser33, Ser37 and Thr41 at the N-terminus45.  
At the C-terminus in GSK3 a hydrophobic groove connects to Axin, and the active site of 
GSK3 may then phosphorylate β-catenin at the N-terminus, which makes a docking site for 
the E3 ubiquitin ligase33. 
 
In the nucleus 
Groucho is a non-DNA binding co-repressor46 that binds to TCF/LEF together with HDAC 
(histone deacetylase) and inhibits transcription of genes47, 48. 
 
1.3.3 The canonical Wnt signaling pathway – ON-State 
 
The Wnt proteins are the ligands that turn this signaling pathway on28. They are secreted 
signaling molecules with a huge variety of functional properties, and are therefore defined 
by their amino acid sequence49. They have a similarity of at least 18 %50. By October 2009 
there were 19 described human Wnt genes with similarity between 27 % and 83 %, coding 
for proteins of 350 to 400 amino acids49, 51. All of them have several highly charged amino 
acid residues, and they all also have 23-24 conserved cysteine residues49. Wodarz & Nusse 
have suggested that Wnts may be divided into two classes, the XWnt-8 class that may lead 
to axis duplication in Xenopus, and the XWnt-5A class that does not lead to axis 
duplication52. This is consistent with the classification into a canonical Wnt1-class and a 
non canonical Wnt5a-class. 
After the Wnt-proteins are secreted from the cell they may interact both with the cell they 
were secreted from, neighbor cells, and cells that are up to 20-30 cell diameters distant 
from the secreting cell53, 54.  
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At the cell surface 
At the cell surface Wnt-proteins may interact with a family of serpentine receptors called 
Frizzled (Frz), and a family of co-receptors called low-density lipoprotein receptor-related 
proteins (LRP)55, 56.  
Frz is a family of transmembrane proteins that cross the cell membrane seven times57, 58, 59. 
It has an amino-terminal extension that contains a signal sequence, and a highly conserved 
cysteine-rich domain (CRD) of 10 amino acids (aa) that Wnt may bind to outside the cell57, 
58, 59. A linker containing 40-100 aa that is different from protein to protein binds the CRD 
to a transmembrane segment57, 58, 59. Loops join the seven transmembrane segments, and a 
tail inside the cell may transfer the signal further57, 58, 59.  
LRP is also a transmembrane protein, but it only crosses the cell membrane once. It has a 
large domain outside the cell, and a smaller domain in the cytosol. It has been suggested 
that LRP changes conformation when Wnt binds to it, and that this leads to binding to 
Frz58, 59. 
 
In the cytoplasm 
Dishevelled (Dvl) is a phosphoprotein that can interact with several signal components. It 
is buildt up of three highly conserved domains; DIX, PDZ, and DEP. At the amino-
terminal end there is a 50 aa domain called DIX, which has its name from Dvl and Axin 
because it has an area that is similar to Axin60, 61. The central region contains a PDZ 
domain with 80-90 amino acids62. This domain has its name from the three first proteins 
that were discovered to contain PDZ; Post synaptic density protein (PSD95), Drosophila 
disc large tumor suppressor (DlgA) and zonula occludens-1 protein (zo-1). At the carboxy-
terminal there is a DEP domain. The DEP-domain has its name from Dvl, Egl-10, and 
Pleckstrin. 
In the presence of Wnt binding, the scaffolding protein Dvl is phosphorylated on serine 
and threonine residues by several kinases, among others casein kinase 2 (CK2) 63.   
 15
Dvl will then be attached to the cell membrane, and will here help LRP aggregate and be 
phosphorylated by CK1γ64 at T1479 in the intracellular domain of LRP64, in addition to 
phosphorylation by GSK3β. The phosphorylation of LRP will give Axin a higher affinity 
for LRP than for the proteins in the destruction complex, and the destruction complex will 
not be formed65.  
β-catenin will not be ubiquitinated and degraded to the same extent, and its concentration 
in the cytoplasm will increase. Some of the β-catenin will translocate to the nucleus66.  
 
In the nucleus 
After the β-catenin enters the nucleus it functions as a temporary framework to bind T-cell-
specific transcription factor/lymphoid enhancer-binding factor 1 (TCF/LEF) to the Wnt 
target genes and trigger a transcription of these genes67. A list of 117 target genes and 14 
feedback target genes can be found at The Wnt Homepage68, 69. 
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1.4 Small molecules in inhibition or activation of the canonical 
Wnt signaling pathway 
An inappropriately activated canonical Wnt signaling pathway could lead to a range of 
human diseases and numerous cancers. Small molecules that will modulate the canonical 
Wnt signaling pathway could therefore prove to be important in the making of 
pharmacological agents. Several screenings have already been performed to find small 
molecules that affect the signaling pathway at different levels71, 72, 73, 74, 75. 
 
Lithium chloride is one of the most effective chemical treatments for bipolar disorder. 
Klein and Melton70 found that lithium may inhibit GSK3, which is one of the components 
in the canonical Wnt signaling pathway. 
 
Zhang et al71 screened a library of 100.000 small molecules to find a molecule that 
synergize with Wnt-3A. They found a purine derivative, QS11, which bound to a GTPase 
(ARFGAP1) and inhibited its function. Figure 3 shows the identified small molecule. 
 
Figure 3 Structure of QS1171. 
 
Bodine et al72 screened 440.000 drug-like compounds for inhibitors of secreted frizzled-
related protein 1 (sFRP-1), and found a diphenylsulfone sulphonamide that inhibited 
human sFRP-1 in U2-OS cells. sFRP-1 is a Wnt antagonist, and inhibition of this protein 
will lead to activation of the canonical Wnt signaling pathway. 
 
Figure 4 Structure of a diphenylsulfone sulphonamide that inhibit human sFRP-172. 
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Huang et al73 identified a small molecule that could prolong the halflife of Axin and 
promote β-catenin degradation through inhibiting tankyrase (TNKS). Figure 5 shows the 
structure of the identified small molecule. 
 
Figure 5 Structure of XAV93973. 
 
Zhong et al74 screened a chemical library of 4000 compounds and indentified a GSK3 
inhibitor (Figure 6). 
 
Figure 6 Structure of GSK3 inhibitor 74. 
 
Emami et al75 screened a library of 5000 small molecule compounds, and found a 
compound that inhibited the canonical Wnt signaling pathway by binding to cyclic AMP 
response element-binding protein (CBP). CBP is one of the transcriptional coactivators of 
β-catenin. Figure 7 shows the structure of the CBP binding compound. 
 
Figure 7 Structure of CBP binding compound75. 
 
These examples show some of the types of small molecules that affect the different parts of 
the canonical Wnt signaling pathway. Most of them contain aromatic rings, some contain 
lactam and cyclic amine, but a structure as simple as LiCl also affects this signaling 
pathway.  
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1.5 The Sonic hedgehog signaling pathway 
The hedgehog signaling pathways is largely involved in embryo development and cell 
division of adult stem cells in a variety of species. 
In mammalian species the hedgehog-family of ligands are called Sonic hedgehog (Shh), 
Desert hedgehog (Dhh) and Indian hedgehog (Ihh).  
Figure 8 shows the main steps, and a very brief description of the hedgehog signaling 
pathway in vertebrates follows 76, 77. 
 
 
Figure 8 Simplified illustration from Cell Signaling Technology77 of the hedgehog signaling pathway in 
vertebrates. 
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OFF-state 
Receptors at the cell surface, called Patched (Ptch), act as suppressors on a protein called 
Smoothened (Smo) in the absence of the hedgehog ligand, and prevents this protein from 
translocating to the primary cilium. 
A transcription factor called Gli will be phosphorylated by PKA, CK1 and GSK3, and a β-
TrCP-mediated degradation of Gli activators or generation of repressor-Gli will follow. 
This will lead to repression of hedgehog target genes. 
ON-state 
The hedgehog ligands go through multiple processing steps before a dually lipid-modified 
hedgehog ligand with a N-terminal signaling domain will be secreted from Dispatched in 
the secreting cell. The hedgehog ligands will be transported over both short and long 
distances in the body, and will eventually bind to Ptch. This will translocate Smo to the 
primary cilium. Gli translocates to the nucleus and activate hedgehog target genes. 
 
1.6 The NF-κB (nuclear factor kappa B) signaling pathway 
The NF-κB signaling pathway plays a huge role in immune- and inflammatory responses. 
This signaling pathway can be activated in a wide range of ways, stimulation by the 
proinflammatory cytokine tumor necrosis factor α (TNF-α) being one of them. 
Figure 9 shows the main steps in this very complex signaling pathway, and a very brief 
description of the NF-κB signaling pathway activated with TNF-α follows78. 
OFF-state 
A family of inhibitors, called IκBs (inhibitors of κB), bind to NF-κB in the cytoplasm and 
prevent it from entering the nucleus. 
ON-state 
TNF-α bind to its receptor at the cell surface, and this will finally lead to phosphorylation 
of the IκBs. β-TrCP will then mark the IκBs for ubiquitination and proteosomal 
degradation. The transcription factor NF-κB will be translocated into the nucleus and bind 
the DNA at κB binding motifs. 
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Figure 9 Simplified illustration from abcam78 of the NF-κB signaling pathway. 
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1.7 Cells and methods 
1.7.1 Cells and conditioned medium 
Human embryonic kidney 293 wild type (HEK293 wt) cells is a cell line generated from a 
healthy aborted fetus in early 1970s, and the cell line was first described in 197779. This 
cell line is widely used in cell biology research because it is easy to grow and transfect 
very readily. For our purpose it is suitable because it contains the components of the 
canonical Wnt signaling pathway, except Wnt itself. HEK293 are not Wnt producing cells. 
These cells also contain the components of the NF-κB signaling pathway but are not NF-
κB producing cells.  
HEK293 Super TOP-Flash (STF) cells contain the integrated variant of the Wnt/β-catenin-
responsive luciferase reporter Super TOP-Flash, which gives us an excellent way to 
measure the response to activation by Wnt. This cell line is clonally selected for high 
sensitivity (strong signal) for the canonical Wnt signaling pathway. (For more information 
about luciferase assay and STF see section 1.7.4 and 1.7.5) 
Sonic hedgehog (Shh)-Light 2 cells are derived from the NIH/3T3 cell line (mouse 
embryonic fibroblast cells)80 and contain the integrated variant of the GLI-responsive 
firefly luciferase reporter and a Renilla luciferase expression vector. This cell line contains 
the components of the Shh signaling pathway. (For more information about luciferase 
assay, GLI-responsive firefly luciferase and Renilla luciferase see section 1.7.4 and 1.7.5). 
 
Conditioned medium is per definition medium collected from a growing cell line which 
secret biologically active components, and these components will affect some cell 
functions (e.g. signaling pathways)81. 
To activate the canonical Wnt signaling pathway, Wnt-proteins have to be added. Murine 
L1 cells stably transfected with a Wnt-3A expression vector82 produce and secrete Wnt-3A 
proteins, which are known to activate the canonical Wnt signaling pathway, and Wnt-3A 
conditioned medium (also called L1-medium) can be obtained from these cells. 
Conditioned Shh-medium is collected from PANC-1 cells (human pancreatic carcinoma, 
epithelial-like cell line) stably transfected with a Shh expression vector. 
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1.7.2 Coating well plates with poly-L-lysine 
When well plates are coated with poly-L-lysine hydrobromide (molecular formula: 
(C6H12N2O2)n.xHBr) the adhesion increases and the chance of cell loss will be reduced. 
Poly-L-lysine improves electrostatic interactions, by increasing the number of positively 
charged ions on the well surface so the negatively charged ions of the cell membrane will 
have more binding sites83. Figure 10 shows the chemical structure of poly-L-lysine 
hydrobromide. 
 
 
Figure 10 Chemical structure of poly-L-lysine hydrobromide from chemBlink84. 
 
 
1.7.3 Transfection 
Transfection is the process by which exogenous DNA or RNA is introduced into cells85. A 
vector is in molecular biology and genetics defined as a DNA molecule used to transfer 
this exogenous DNA or RNA into the cell86, 87. 
DNA can be transfected into the cell as a plasmid (a type of vector). A plasmid is per 
definition a circular molecule of double stranded DNA that can be replicated inside the cell 
(independent of the chromosomal DNA)88. The plasmid DNA can be stably transfected 
into the cells genome or transiently transfected into the cell89.  With the DNA transiently 
transfected, it will be degraded and diluted through mitosis and the expression will only 
occur in a short period of time90. By chance some of the plasmid DNA will be included 
into the genome, and by adding a selection marker (gene for drug resistance) into the 
plasmid only the cells with the plasmid integrated into the genome will survive when 
treated with the selection chemical91. This selection will give a cell line with the plasmid 
stably integrated into the cells genome, and the genes from the plasmid will be replicated 
along with the rest of the DNA through mitosis. 
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Two stably transfected cell lines were used in this master thesis; HEK293 STF cells and 
Shh-Light2 cells. Transiently transfection was used on HEK293 wt cells with a 
combination of one reporter plasmid and one constitutive plasmid (STF plasmid as a 
reporter for the canonical Wnt signaling pathway and NF-κB-luc plasmid as a reporter for 
the NF-κB signaling pathway, and a Renilla plasmid as a constitutive plasmid for internal 
control. See section 1.7.4 and 1.7.5).  
 
Several methods can be used to transfect DNA into cells, but only chemical-based transient 
transfection with FuGENE-6™ has been used in this master thesis. FuGENE-6™ is a 
cationic lipid that will bind to the negatively charged DNA. Endocytosis will then transport 
the DNA/ FuGENE-6™ complex into the cell92. 
 
1.7.4 Luciferase assay 
Activation of the canonical Wnt signaling pathway will lead to transcription of a range of 
genes, and to quantify the activation of the signaling pathway the gene transcription needs 
to be quantified. Luciferase assay is a method used to relate luciferase-mediated 
bioluminescence to the activation of a signaling pathway such as the canonical Wnt 
signaling pathway, or other cellular events coupled to gene expression. 
A type of enzyme, called luciferase, catalyzes the oxidation of the organic molecule 
luciferin, and this reaction leads to emission of light that is proportional to the amount of 
luciferase in the reaction93. 
 
Several different types of luciferase can be used, and in this master thesis the Photinus 
pyralis firefly luciferase and the Renilla reniformis Renilla luciferase were employed. 
The enzyme Photinus pyralis firefly luciferase catalyzes oxidation of Photinus luciferin 
while Renilla reniformis Renilla luciferase catalyzes oxidation of Renilla luciferin (see 
Figure 11)93, 94, 95, 96, 97, 98. 
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Figure 11 The oxidation reactions used in a Dual-Luciferase Reporter Assay (coelenterazine is a synthetic 
Renilla luciferin)98. 
 
Both firefly luciferase and Renilla luciferase can be used as genetic reporters to measure 
the transcription of other genes94, 97. This is done by attaching the reporter gene (luciferase) 
to the regulatory sequence of the gene that will be transcribed when e.g. the canonical Wnt 
signaling pathway is activated. When this other gene is targeted for transcription, the 
luciferase gene will also be transcribed.  
 
In this master thesis only the firefly luciferase was used as a reporter gene, while the 
Renilla luciferase was used as a constitutive active gene in some of the experiments to 
provide an internal control of cell viability and transfection rate (Dual-Luciferase Assay 
System)98. 
 The genes coding for the enzymes are placed inside the cells (stably transfected into the 
genome of a cell line or transiently transfected, see section 1.7.3), and the constitutive gene 
will be transcribed all the time while the reporter gene will be transcribed when the 
signaling pathway is activated. To measure the transcription of the genes, luciferin is added 
before measuring the luminescence with a luminometer. With a Dual-Luciferase Assay 
System Beetle Luciferin is added and the luminescence is measured, then this reaction is 
stopped and Coelenterazine is added, and the luminescence is measured again (see section 
2.7). 
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In this master thesis, the luciferase assay has been used with: 
1) HEK293 STF cells: a stably transfected cell line with only canonical Wnt-responsive 
firefly luciferase. 
2) Shh-Light2 cells: a stably transfected cell line with both firefly luciferase (GLI-
responsive) and Renilla luciferase. 
3) Transient transfection with both firefly luciferase and Renilla luciferase on HEK293 wt 
cells. NF-κB-responsive firefly luciferase (NF-κB-luc plasmid) for the NF-κB signaling 
pathway, and canonical Wnt-responsive firefly luciferase (STF plasmid) for the canonical 
Wnt signaling pathway. 
 
1.7.5 Plasmids 
A plasmid is as mentioned in section 1.7.3 a type of vector. A plasmid generally contains a 
promoter, the gene(s) to be transcribed, and a polyA tail. The promoter facilitates the 
transcription and can be constitutive (continuously transcription) or inducible (induced by 
the presence or absence of other factors).The polyA tail terminates the transcription and 
adds adenosine residues to increase the stability and translation of the RNA transcript.  
In addition a gene that confers antibiotic resistance and an origin of replication (where the 
replication is initiated) is often present in the plasmid. 
The Renilla plasmid pRL-TK was used in this master thesis as an internal control for the 
transfection and viability of the cells. The pRL-TK Vector circle map from Promega is 
shown in Figure 12.  
 
Figure 12 The pRL-TK Vector circle map and sequence reference points99. A HSV-TK (herpes simplex virus 
thymidine kinase) promoter ensure constitutive expression of the Renilla luciferase reporter gene (Rluc), and 
the SV40 late poly(A) add 200-250 adenosine residues to the transcript. 
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As the reporter vector for the canonical Wnt signaling pathway a construct called 
Super8xTOPFlash (made by Ajamete Kaykas in the Moon lab) was used in this thesis. The 
vector circle map is shown in Figure 13. The cell line HEK293 STF has this plasmid stably 
transfected into its genome. 
 
Figure 13 The Super8xTOPFlash Vector circle map and sequence reference points100. 
This construct is made up of a pTA-Luc vector backbone (which drives the expression of the firefly 
luciferase) from Clontech and with 7 TCF/LEF binding sites incorporated100 to get the firefly luciferase gene 
transcribed when the canonical Wnt signaling pathway is activated. 
 
As the reporter vector for the NF-κB signaling pathway a construct called NF-κB-Luc was 
used in this master thesis. This reporter vector contains NF-κB response element (κB4) 
bound to a TATA-like promoter (PTAL). When NF-κB is translocated into the nucleus it 
will bind to κB4 and induce transcription of the reporter gene firefly luciferase (luciferase). 
A SV40 polyA add adenosine residues to the transcript. 
With the Shh signaling pathway a stably transfected cell line (Shh-Light2) derived from 
the NIH/3T3 cell line (mouse embryonic fibroblast cells)80 and transfected with GLI-
responsive firefly luciferase reporter and a Renilla luciferase pRL-TK.  
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1.7.6 Real-Time reverse transcription-polymerase chain reaction 
Polymerase chain reaction (PCR) is a technique used to generate many copies of a specific 
DNA sequence, invented already in 1971101. Reverse transcription-PCR (RT-PCR) is a 
variant of PCR where an RNA strand is reverse transcribed into its complementary DNA 
(cDNA) by using the enzyme reverse transcriptase. This cDNA is then amplified using 
PCR. Real-time RT-PCR is used to monitor the advancement of a PCR reaction in real 
time, and to quantify the targeted DNA molecule102. 
The mixture for the real-time RT-PCR needs to contain cDNA, DNA polymerase, and 
primers. Before elaborating on the DNA polymerase and the primers, the obtaining of the 
cDNA will be explained. 
24 hours after treating HEK293 wt cells with compounds and conditioned medium, the 
RNA from the cells are released by cell lysis. Mercaptoethanol is added to inhibit 
formation of ribonucleases (RNases, which catalyzes the degradation of RNA), by 
breaking disulfide bonds103. The RNA is purified using manufacturers procedure. 
After the mRNA concentration is measured according to their optical density with a 
spectrophotometer, cDNA is synthesized from the mRNA by using an enzyme called 
reverse transcriptase. Dithiothreitol (DTT) is added to inhibit RNases. The mixture also 
contains deoxynucleoside triphosphates (dNTP) which are the building blocks for DNA 
strands, and a random hexamer primer that binds at non-specific point along the RNA 
template to synthesize all the RNA to cDNA. 
The produced cDNA is mixed with the SYBR® Green PCR Master Mix, which contains a 
dye called SYBR Green 1 which is used to detect and quantify the gene transcripts. This 
dye binds non-specifically to double-stranded DNA, and has an excitation maximum at 
497 nm and an emission maximum at 520 nm104. The SYBR® Green PCR Master Mix also 
contains AmpliTaq Gold® DNA Polymerase and dNTPs. A passive reference dye to 
normalize pipetting volumes is also added, and the one most commonly used is ROX™ 
Passive Reference Dye. The primers to be used are also added to this mix. A primer is in 
molecular biology and genetics defined as a strand of nucleic acid (DNA or RNA) that is 
complementary to a given DNA sequence and serves as a starting point for DNA 
replication by the enzyme DNA polymerase105, 106. One set of primers (forward and 
reverse) is needed for each cDNA sequence we want to replicate. Glyceraldehyde-3-
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phosphate dehydrogenase (GAPDH) is often used as an internal reference gene to 
normalize the expression levels107. 
The PCR-method is based on thermal cycling, but before the cycles starts the mixture is 
heated up to 94-96 °C for 1-9 minutes to denaturize all the DNA. The thermal cycling 
consists of three steps which are repeated 20-40 times. The first step is to denature the 
DNA, which is done by heating the mixture to 94-96 °C, but only for 20-30 seconds. The 
next step is to help the primers anneal to the single stranded DNA, by lowering the 
temperature to 50-65 °C (dependent on the primers used) for 20-40 seconds. In the last step 
the DNA polymerase synthesizes a new DNA strand complementary to the DNA template 
strand. The temperature in this step is dependent on the DNA polymerase used (as an 
example Taq polymerase needs 75-80 °C to function optimal). After the cycles are 
finished, a final elongation is performed at 70-74 °C for 1 to 15 minutes to make sure the 
entire single-stranded DNA is extended.  
Software can be used to perform automated gene expression analysis to quantify and 
normalize the results from the Real-Time RT-PCR. 
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1.8 The aim of this master thesis 
 
The canonical Wnt signaling pathway controls embryo development and adult stem cell 
maintenance. When incorrectly activated, the canonical Wnt signaling pathway may lead 
to a range of human diseases, including cancers16, 22, 23, Alzheimers17, multiple sclerosis18 
and arthritis21. To have the power to control the canonical Wnt signaling pathway and 
correct improperly activation could possibly treat or prevent these diseases. As mentioned 
in section 1.4, LiCl is used to treat bipolar disorder (lithium inhibits GSK3 beta, which is 
one of the main players in the canonical Wnt signaling pathway). 
The importance of adjusting this signaling pathway led to the search for small molecules 
that influence different steps in the canonical Wnt signaling pathway. Several small 
molecules other than LiCl have been found to have an effect (see section 1.4).  
In addition to the search for pharmacological agents, the small molecules may also be used 
as scientific experimental tools for examination of other components of the signaling 
pathway, both in vivo and in vitro. 
 
In this master thesis the binding between the Wnt ligand and the Frizzled receptor has been 
in focus. Finding a small molecule that increased or decreased the binding between Frz and 
Wnt giving a synergistic or inhibitory effect, was the aim of the study.  
A computer based (in silico) screening of 10.000 compounds done by Andrew Voronkov 
prior to the study (see section 2.9) limited the laboratory screening to 256 compounds. 
From these 256 small molecules the best inhibitors and/or the best synergists were to be 
found. Analogues of the most promising compounds from the screening were also going to 
be examined to see if even better inhibitors and/or synergists could be found. 
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2 Experimental – kits, materials and methods 
2.1 Cell culture and plating of cells 
Adherent cell lines were used, and grown in 25 cm2, 75 cm2 and 175 cm2 sterile Nalge 
Nunc EasyFlask Culture flasks (NUNC – Rochester, NY, USA). 
HEK293 STF cells, kindly provided by prof. dr. Vladimir Korinek (IMG, ASCR, Prague, 
Czech Republic), HEK293 wt cells (ATCC – Manassas, VA, USA), murine L1 cells stably 
transfected with Wnt-3A expression vector (ATCC), and Shh-Light2 cells (ATCC) were 
all sub cultured two or three times a week in Dulbecco’s modified Eagle’s medium 
(DMEM) with GlutaMAX™-1 (Invitrogen™ - Carlsbad, CA, USA) supplemented with 
10% (v/v) inactivated Foetal Bovine Serum (FBS) (Invitrogen™) and 1% (v/v) Penicillin 
streptomycin (Pen Strep, PS) (BioWhittaker® – Walkersville, MO, USA) (abbreviated 
DMEM/FBS/PS, or referred to as regular cell medium from now on). HEK293 STF, L1 
and Shh-Light2 cells were supplemented with 0.25 µg/µL Geneticin G418 (Invitrogen™), 
and Shh-Light 2 cells were also supplemented with 0.25 µg/µL Zeocin (Invitrogen™). 
Phosphate buffered saline, PBS (Rikshospitalet, Norway) (see Attachment 1: Recipes), was 
used to wash away rests of medium, before trypsination with Trypsin-
ethylenediaminetetraacetic acid (Trypsin-EDTA) (BioWhittaker®) to loosen the cells from 
the surface inside the growth flask. 
A counting chamber (Bürker, Germany) was used to determine the concentration of 
cells108. 
To do the experiments, the cells were evenly distributed in wells in a well-plate (wp) 
(NUNC). For HEK293 wt and HEK293 STF cells, plates coated with poly-L-lysine were 
used. 80k cells per well (c/w) was added to each well to a final volume of 500 µL in a 48 
wp, and 320k c/w to each well to a final volume of 2 mL in a 12 wp. For Shh-Light2 cells 
100k c/w was added to each well in a 48wp. DMEM/FBS/PS-medium was used for all the 
plated cells, and the cells were grown overnight before adding compounds. 
L1 cells were used to make Wnt-3A conditioned medium (2.2.1). 
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2.2 Production of conditioned medium and other medium 
2.2.1 L1-medium 
3 mL Trypsin-EDTA was added to the 75 cm2 cell flask with L1-cells of approximately 
100% confluence, after removing the medium and washing with PBS. After 5 minutes 
incubation the mixture was gently homogenized and 0.66 mL were transferred to a 175 
cm2 cell flask. 31.25 mL DMEM/FBS/PS were added. After 72 hours the medium was 
carefully removed from the flask without detaching the cells. 31.25 mL new medium 
(DMEM/FBS/PS) was added to the flask. The old medium was sterile filtrated through 
Whatman® 0.2 µm filter (GE Healthcare, England) and stored at 4°C (M1). After 96 
hours, the medium on the cells was carefully removed from the flask, and the flask was 
thrown away. The collected medium was sterile filtrated (M2) and combined with M1. 
2.2.2 Shh-medium 
Conditioned Shh-medium was kindly provided by Martin Strand (Cellular and Genetic 
Therapy Research Group, Institute of Microbiology, Rikshospitalet, Norway) from Shh-
PANC-1 (Human pancreatic carcinoma, epithelial-like cell line) cells stably transduced 
with a mouse Shh-expression vector. 
2.2.3 Medium with TNF-α 
Recombinant rat TNF-α (R&D Systems – Minneapolis, MN, USA) was dissolved in 
DMEM/FBS/PS to a final concentration of 10 ng/mL. 
 
2.3 Poly-L-lysine; preparing stock solution and coating plates 
A 5 mg/mL stock solution was prepared by solving 100 mg poly-L-lysine hydrobromide 
(15-30k mol.mass) (Sigma-Aldrich – St.Louis, MO, USA) in 20 mL Milli-Q (MQ) H2O 
(Milli-Q® systems, Millipore – Billerica, MA, USA), aliquoted into 1.5 mL eppendorf 
tubes (VWR – West Chester, PA, USA) and stored at -20°C. 
For coating of the plates a solution of 70 µg/mL was used, made by appropriate dilution of 
the stock solution. The solution was added to the wells, left for 2 hours and then the wells 
was washed twice with autoclaved MQ-H2O. The wells were dried before use. 
 32
2.4 Adding compounds to investigate their effect on endogenous 
luciferase activity the Wnt/β-catenin signaling pathway 
HEK293 STF cells were plated in a 48 wp coated with poly-L-lysine and grown overnight. 
Each compound dissolved in dimethyl sulfoxide (DMSO) (Promega) to be investigated 
was added to an Eppendorf tube (Eppendorf HQ – Hamburg, Germany), and then mixed 
with conditioned Wnt-3A medium or with DMEM/FBS/PS. The mixture was vortexed and 
carefully added to the wells without detaching the cells. DMSO was added to the negative 
and positive controls because the compounds were dissolved in DMSO. After 
approximately 24 hours the Luciferase activities were measured (2.7). 
 
2.5 Adding compounds to investigate their effect on the Shh-
signaling pathway 
Shh-Light2 cells were plated in a 48 wp and grown overnight. A compound dissolved in 
DMSO was added to a tube, and then mixed with conditioned Shh medium. The resulting 
mixture was vortexed and carefully added to a well without detaching the cells. DMSO 
was added to the negative and positive controls. After approximately 48 hours the 
Luciferase activities were measured (2.7). 
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2.6 Transfection with FuGENE® 6 
HEK293 wt cells were plated in a 48 wp coated with poly-L-lysine and grown overnight. 
The transfection was performed with FuGENE® 6 Transfection Reagent (Roche – Basel, 
Switzerland), using standard protocol from Roche (Version February 2006) with a ratio 3:1 
of FuGENE® 6 (µL) : plasmid (µg) (0.75 µL FuGENE® 6, 0.25 µg plasmid). OPTI-
MEM® I Reduced Serum Media (modification of MEM)(Invitrogen™) was used.  
A mixture of two plasmids constituted the 0.25 µg of plasmid in the ratio, and the types of 
plasmids depended on the signaling pathway under investigation. 
To investigate the canonical Wnt signaling pathway, a Super TOP-Flash plasmid (pSTF) 
(Promega) with a stock solution of 2.265 µg/µL, and a Renilla plasmid (pRL-TK) 
(Promega) with stock solution 10 ng/mL were used.  
To investigate the NF-κB signaling pathway, a pNF-κB-luc (Panomics – Fremont, CA, 
USA) with a stock solution of 1 µg/µL was used together with the Renilla plasmid. 
In a 48 wp each well was added 20 ng of the Renilla plasmid and 230 ng of the STF 
plasmid or the NF-κB plasmid. 
18 hours after transfection the compound (dissolved in DMSO) to be investigated was 
added to a tube, and then mixed with either conditioned Wnt-3A medium (canonical Wnt 
signaling pathway and pSTF), or 10 ng/mL TNF-α-medium (NF-κB signaling pathway and 
pNF-κB). The mixture was then vortexed and carefully added to a well without detaching 
the cells. DMSO (Promega) was added to the negative and positive controls. After 
approximately 24 hours the Luciferase activities were measured (2.7). 
 
2.7 Luciferase activity measurement 
Luciferase activity measurement was performed with either a Dual-Luciferase® Reporter 
Assay System (Promega – Sunnyvale, CA, USA) or with a Luciferase Assay System 
(Promega), and with standard protocols from Promega (Part# TM040 and Part# TB281).  
The activities were measured with a 20/20n Luminometer (Turner BioSystems/Promega). 
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2.8 Real time RT-PCR 
HEK293 wt cells were grown in a 12 wp, 320 k c/w. Extraction of RNA from cells was 
performed using a Genelute Mammalian total RNA kit (Sigma), and a standard protocol 
(RTN 350, 70, 10).  
The mRNA concentrations were measured by adding 200 µL Tris-EDTA (TE) buffer 
(Rikshospitalet, Norway) (see Attachment 1: Recipes) to 2 µL mRNA solution. After 
pipette mixing, vortex mixing and a rapid centrifugation for 2-5 seconds the mRNA 
concentration was measured according to their optical density in an Ultrospec™ 2100 pro 
UV/Visible Spectrophotometer (GE Healthcare). 
The cDNA synthesis was performed using AffinityScript™ Multiple Temperature Reverse 
Transcriptase (Stratagene – La Jolla, CA, USA) and a standard protocol (Catalog 
#200436). Brilliant® SYBR® Green QPCR Master Mix (Stratagene) with standard 
protocol (Catalog #600548) was used to make the PCR reaction mixture.  
The primers used were: 
Axin2 forward: 5’-CCCAAGCCCCATAGTGCCCAAAG-3’ 
Axin2 reverse: 5’-CAGGGGAGGCATCGCAGGGTC-3’ 
GAPDH forward: 5’-GCCCCCTCTGCTGATGCCCCCA-3’ 
GAPDH reverse: 5’-TGGGTGGCAGTGGCATGG-3’ 
The Stratagene Mx3000P QPCR System (SuperArray Bioscience Corporation – Frederick, 
MD, USA) was used for the Real Time RT-PCR. (Initial denaturation at 95°C for 5 
minutes. 40 cycles of denaturation, annealing and amplification using 95°C for 30 seconds, 
60°C for 30 seconds, and 72°C for 60 seconds. Ending performed at 95°C for 60 seconds.) 
MxPRO™ QPCR Software (Stratagene) was used to perform automated gene expression 
analysis to quantify and normalize Axin2 against GAPDH. 
 
2.9 Compounds 
Totally 482 compounds (C1089-C1344, C1355-C1580) were provided by ChemDiv (San 
Diego, CA, USA). The structures may not be revealed due to secrecy until publication by 
the Section for Cellular and Genetic Therapy, Institute of Microbiology, Rikshospitalet, 
Norway. The compounds were dissolved in DMSO to a concentration of 10 mM and kept 
at 4 °C until use.
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Selection of compounds was carried out by Andrew Voronkov (Moscow State University, 
Department of Chemistry), and the following page is written by him: 
 
As initial protein structure of CRD domains the structure 1ijy from protein databank 
(RCSB.org) was used (Ref. 1). This structure corresponds to CRD domain of Frizzled 8 
mice receptors. The water molecules were removed from the 1ijy structure, which then was 
used to construct homology based models of CRD domains for other human Frizzled 
receptors. After homology based modelling the structures quality was evaluated by 
ProCheck module of Sybyl7.1 software (Ref. 2). The hydrogens and Kollman_all charges 
were added to protein structures. The protein geometry was then optimized by molecular 
mechanics methods using Tripos force field (Ref.3). 
Initial database of 10 000 compounds from ChemDiv diversity set was used for virtual 
screening procedure through each of dimeric CRD domains of Frizzled receptors. Virtual 
screening procedure was performed using Gold3.1 software at Moscow State University. 
The binding sites on CRD domains interface were chosen (sites 2, 3, 4 on the Fig.1). The 
binding sites were selected based on protein-protein docking studies of Wnt protein with 
dimeric CRD domain and according the experimental data on point mutagenesis (Fig.2). 
The compounds for the next receptors were selected: Frizzled 6, Frizzled 7, Frizzled 8 as 
dataset of 250 compounds after screening. These compounds were sent for experimental 
trials to Professor Stefan Krauss group. 
 
 
Fig. 1 Potential small molecule action 
sites on the surface of Wnt protein and 
dimeric CRD domains of Frizzled 
receptors 
 
 
Fig. 2 Point mutagenesis data visualised on 
dimeric CRD domain. Blue – amino acids which 
are supposed to be important for CRD domain 
dimerization. Green – amino acids which are 
supposed to be important for Wnt binding. Yellow  
- amino acids which are supposed to be 
responsible for correct orientation agains 
transmembrane part of Frizzleds. 
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2.10 Calculations 
 
The relative luciferase activity in %, A(%), was calculated by: 
 
where X is the measured luciferase activity of the sample,  is the average of the 
negative controls, and  is the average of the positive controls. 
 
The relative luciferase activity in % without activation of the canonical Wnt signaling 
pathway, B(%), was calculated by: 
 
where X is the measured luciferase activity of the sample,  is the average of the 
negative controls. 
 
The normalized relative luciferase activity in %, C(%), was calculated by: 
 
                
where X is the ratio between the measured luciferase activity of the sample and the 
measured Renilla activity of the sample,  
 is the average of the ratios between the measured luciferase activity for the 
negative controls and the ratios between the measured Renilla activity for the negative 
controls, and  
 is the average of the ratios between the measured luciferase activity for the 
positive controls and the ratios between the measured Renilla activity for the positive 
controls 
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The strength of the conditioned medium, D, was calculated by: 
 
where  is the average of the negative controls and  is the average of the 
positive controls. 
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2.11 Flowchart of methodology 
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3 Results and Discussion 
The aim of the present study was to find small molecules that increased or decreased the 
binding between Frizzled and Wnt in the canonical Wnt signaling pathway in order to 
increase or decrease the transcription of target genes. 
Prior to the present study, Andrew Voronkov has used an in silico based screening (see 
section 2.9) to find compounds that could possibly increase or decrease the binding 
between Frizzled and Wnt. From this modeling 256 compounds was chosen for further 
screening and examination in the laboratory. The structures of these 256 compounds were 
not revealed prior to the screening and examination, and only a few of the structures were 
revealed at the end of the examination of these 256 compounds. But due to secrecy until 
publication at Section for Cellular and Genetic Therapy (Institute of Microbiology, 
Rikshospitalet, Norway), the author can not reveal the structures in this master thesis. 
 
3.1 Screening of 256 compounds using HEK293 STF cells and 
Luciferase Reporter Assay 
HEK293 STF cells are HEK293 cells with a STF reporter vector stably integrated into the 
genome. HEK293 cells are very easy to grow and are often used in cell biology research, 
so the results obtained may easily be compared to other research. The STF reporter vector 
will be transcribed when the canonical Wnt signaling pathway is activated with a Wnt 
ligand. The transcription will generate a luciferase enzyme that catalyzes an oxidation of 
luciferin, which results in emission of light which is measured with a luminometer. By 
using cells with a STF reporter vector stably integrated into the genome, no transfection 
had to be performed, and the transcription of target genes could be measured with 
luciferase activity instead of using RT-PCR (both transfection and RT-PCR are more time 
consuming methods). One of the advantages of using the Luciferase Reporter Assay on 
HEK293 cells is that mammalian cells have little or no endogenous luciferase activity. 
The purpose of a screening of the compounds using HEK293 STF cells and Luciferase 
Reporter Assay was to find compounds that increased or decreased the luciferase signal 
compared to the controls without added compound. An increased or decreased signal may 
indicate an activating, synergistic or inhibitory effect on the canonical Wnt signaling 
pathway.  
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Two separate small scale screenings of the 256 chosen compounds were carried out on 
HEK293 STF cells. After ~12 hours the cells were stimulated with Wnt-3A conditioned 
medium and treated with the compounds to a final concentration of 20 µM (see section 
2.4). A Wnt-3A ligand will activate the canonical Wnt signaling pathway by binding to Frz 
and LRP, and the compounds under investigation were presumed to increase or decrease 
the binding between Frz and Wnt-3A. The luciferase activity was measured with the 
Luciferase Assay System ~24 hours after adding the compounds. The luciferase values 
were calculated relative (in %) to the average of three negative and the average of three 
positive controls (see section 2.10 A). Wnt-3A treatment alone was used as a positive 
control, and medium without Wnt-3A (DMEM/FBS/PS, from now referred to as regular 
cell medium) were used as the negative control. The negative controls show the 
endogenous luciferase reporter activity. 
A way to characterize the activity and thereby the activating properties of the Wnt-3A 
conditioned medium is to calculate the ratio between the luciferase signal when the cells 
are treated with conditioned Wnt-3A medium (positive control) and the luciferase signal 
when the cells are not treated with conditioned Wnt-3A medium (negative control). In 
these two preliminary screenings the positive to negative ratio varied between 3 and 30. 
For compounds C1089 to C1202 in the first screening the positive to negative ratio was 3, 
while the positive to negative ratio was between 16 and 30 for the rest of the first screening 
and all of the second screening. 
Figure 14 shows the average of the two screenings for the 256 compounds, with error bars 
showing the spread. The luciferase values were calculated relative (in %) to negative and 
positive controls (see section 2.10 A). Compounds with an average of less than 80 % 
(inhibitors) or more than 300 % (activators) in the screenings were chosen for hit 
confirmation. An average relative activation of 80 % is not low enough to be considered as 
a potent inhibitor, but due to the small amount of potentially inhibitors the limit in the 
preliminary screenings was set this high. In Figure 14 the 12 possible inhibitors are marked 
with red while the 33 possible activators are marked with blue. Figure 15 displays the 
average of the two screenings for these 45 compounds and the error bars showing the 
spread. 
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Figure 14 The relative luciferase activity in % (2.10 A) for 256 compounds (two experiments with n=1). The 
two screenings were performed on HEK293 STF cells, activated with Wnt-3A conditioned medium, and 
added compounds to a final concentration of 20 µM. Bars show the average of the two screenings, error bars 
show the spread. Colored bars indicate the compounds chosen for hit confirmation (blue for activating 
compounds and red for inhibiting compounds). 
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Figure 15 Summary of potential inhibitors and synergists of the canonical Wnt signaling pathway from the 
screenings, Figure 14. The relative luciferase activity in % (2.10, A) for 45 compounds (two experiments 
with n=1). The two screenings were performed on HEK293 STF cells, activated with Wnt-3A conditioned 
medium and added compounds to a final concentration of 20 µM. Bars show the average of the two 
screenings, error bars show the spread (blue bars for activating compounds and red bars for inhibiting 
compounds). 
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3.2 Inhibitors 
The twelve compounds that indicated an inhibitory effect on the canonical Wnt signaling 
pathway from the two screenings are shown in Figure 16. The luciferase activities in the 
two screenings were calculated relative to the controls in % (2.10 A), and the compounds 
with an average below 80 % were chosen for hit confirmation. 
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Figure 16 Summary of potential inhibitors of the canonical Wnt signaling pathway from the screenings, 
Figure 14. The average of the relative luciferase activity in % (2.10 A) for twelve compounds (two 
experiments with n=1). Bars show the average of the two screenings, error bars show the spread. 
 
3.2.1 Hit confirmation of twelve possibly inhibitory compounds 
To confirm the results from the two screenings (indicated inhibitory effect on the canonical 
Wnt signaling pathway), the twelve compounds were examined again with the same cells 
and method, but in duplicates instead of singlets. For some of the compounds the two 
screenings also showed high variation % relative activity, and this had to be examined to 
confirm or dismiss these compounds as inhibitors. 
The hit confirmation of the twelve compounds was carried out on HEK293 STF cells. The 
Wnt signaling pathway was activated with Wnt-3A conditioned medium, and the 
compounds were added to a final concentration of 20 µM. Two negative controls with 
regular cell medium and two positive controls with Wnt-3A conditioned medium were 
used. The luciferase activities were measured with the Luciferase Assay System, and the 
activities were calculated relative to positive and negative controls (2.10 A) The positive to 
negative ratio (2.10 D) was ~50 in this experiment. Figure 17 shows the hit confirmation 
and the two screenings.  
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Figure 17 The relative luciferase activity in % (2.10 A) for twelve compounds (two screenings with n=1 and 
one hit confirmation with n=2). Performed on HEK293 STF cells, activated with Wnt-3A conditioned 
medium and added compounds to a final concentration of 20 µM. Red bars show the two screenings. Pink 
bars show the average of the hit confirmation with error bars showing the spread.  
 
All the compounds gave a higher relative activation in the hit confirmation, and some of 
the compounds actually showed a synergistic effect. Compound C1270, C1290 and C1336 
gave a relative luciferase activity below 50 % for both screenings and the hit confirmation. 
These three compounds were therefore the most interesting. Because of the varying results 
for the other compounds, they were less interesting, but all compounds were examined 
further. 
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3.2.2 The effect of inhibiting compounds on un-stimulated HEK293 
STF cells 
In addition to increase or decrease the binding between Wnt and Frz, a compound could 
affect the canonical Wnt signaling pathway at another level e.g. in the cytoplasm or in the 
nucleus. It could also affect the luciferase reporter gene by other signaling pathways. The 
compound could affect the oxidation reaction which provides the light, or the compound 
could be toxic and decrease cell growth or kill cells.  
To explore the effect of the compounds on endogenous luciferase reporter activity 
HEK293 STF cells with regular cell medium and the compounds at a final concentration of 
20 µM were used. Luciferase Assay System was used to measure the luciferase activity 
approximately 24 hours after the compounds were added. The luciferase activities were 
calculated relative to an average of four controls without added compound (2.10 B). 
Figure 18 shows the found luciferase activities relative to the controls (in %).  
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Figure 18 The luciferase activities in % relative to negative controls (2.10 B) for twelve compounds (n=2). 
The effect on endogenous luciferase activity was explored on HEK293 STF cells with regular cell medium 
and compounds to a final concentration of 20 µM. Bars show the average, error bars show the spread. 
 
None of the compounds gave increased luciferase signal compared to the controls. Four of 
the compounds gave a luciferase signal between 80 % and 100 % of the controls, and the 
rest of the compounds gave luciferase signals between 30 % and 80 % of the controls. A 
decreased luciferase signal could be due to non-specific binding (binding at other places 
than between Frz and Wnt), or due to a toxic effect because of unspecific binding to other 
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generally important components in a cell. In this master thesis 20 % deviation from the 
control was regarded as normal variation in the endogenous luciferase activity assay. 
The compounds C1270, C1290 and C1336 were the only compounds that gave decreased 
luciferase signals in both screenings and the hit confirmation. All these compounds also 
gave a decreased luciferase signal without Wnt, indicating a possibly non-specific or toxic 
effect. 
 
3.2.3 Transfection with luciferase and Renilla plasmids 
When using HEK293 STF cells and the Luciferase Assay System, no internal control to 
normalize the luciferase activity against is used. A decreased or increased luciferase signal 
could therefore be due to e.g. decreased or increased cell growth. When using the Dual-
Luciferase Reporter Assay, a Renilla vector may be used as an internal control. A 
constitutive expression vector like Renilla luciferase will be transcribed continuously and 
lead to emission of light independent of other factors. Unfortunately the author did not 
have a cell line with both Renilla luciferase and firefly luciferase with canonical Wnt 
signaling reporter vector stably transfected at the time the experiments were performed. 
Therefore transient transfection with a STF plasmid and a Renilla plasmid had to be 
performed. 
This method implies more steps and unfortunately the possibility of more pipetting errors 
in addition to being a more time consuming method compared to the Luciferase Assay 
System on the stably transfected cell line HEK293 STF. The HEK293 STF cell line is also 
clonally selected for high sensitivity (strong signal) for the canonical Wnt signaling 
pathway, and will therefore give a higher response to activation of the canonical Wnt 
signaling pathway compared to the HEK293 wt cell line. In addition to this, transfection 
also cause more stress to the cells. 
Despite of these drawbacks, the Dual-Luciferase Reporter Assay will give complementary 
information about how the compounds affect the canonical Wnt signaling pathway. 
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Two experiments were performed, each in duplicates. The transient transfection with STF 
plasmid and Renilla plasmid (see section 1.7.3 and 2.6) were performed on HEK293 wt 
cells. 18 hours after transfection the canonical Wnt signaling pathway was activated by 
treating the cells with Wnt-3A conditioned medium and the compounds were added to a 
final concentration of 20 µM. Two positive controls with Wnt-3A conditioned medium and 
two negative controls with regular cell medium were used for the first experiment, and four 
positive and four negative controls were used for the second experiment. The luciferase 
and Renilla activities were measured with the Dual-Luciferase Reporter Assay System.  
The ratio between the luciferase activity and the Renilla activity for the compounds were 
calculated relative (in %) to the ratio between the luciferase activity and the Renilla 
activity for negative and positive controls (2.10 C). Figure 19 shows the relative ratios 
between the luciferase activities and the Renilla activities for the twelve compounds. 
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Figure 19 The ratio between the luciferase activity and the Renilla activity relative to controls in % (2.10 C) 
for twelve compounds (two experiments with n=2). HEK293 wt cells transient transfected with STF plasmids 
and Renilla plasmids, activated with Wnt-3A conditioned medium and added compounds to a final 
concentration of 20 µM. Bars show the average, error bars show the spread.  
 
By cell death or decreased cell growth, both the luciferase signal and the Renilla signal will 
be affected. A luciferase to Renilla ratio over 100 % relative to controls suggests an 
activating effect. Contrary to the result from the screenings (see section 3.1), but in 
accordance with some of the results from the hit confirmation (see section 3.2.1) several of 
the compounds showed increased activation in the luciferase signal compared to the 
Renilla signal. A luciferase to Renilla ratio below 100 % could occur because of inhibited 
luciferase signaling compared to Renilla signaling. Only compound C1336 gave an 
average relative luciferase to Renilla ratio below 50 %, and only in the second experiment. 
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3.2.4 Concluding remarks 
 
The average of two preliminary screenings indicated an inhibitory effect for twelve of the 
256 compounds (average below 80% relative to controls). The hit confirmation gave a 
higher activation than the screenings for all the compounds, and only three compounds 
(C1270, C1290 and C1336) gave a relative activation below 80% (25-50%). 
This variation could be due to age of the cells, where the cells are in their cell cycle, age 
and strength of the Wnt-3A conditioned medium, and the stability of the compounds. 
Crystal formation of the compounds could also be a problem; several of the compounds 
were very difficult to get fully dissolved. 
The endogenous luciferase activity assay showed activity compared to controls below 80% 
for eight of the compounds. The low activity could be due to non-specific binding or a 
toxic effect on the cells. Compound C1198, C1221, C1324 and C1325 had activation 
relative to controls between 80 and 110%, indicating no substantial effect on the 
endogenous luciferase activity (in this master thesis the author has defined 20 % deviation 
from the control as normal variation in the endogenous luciferase activity assay). 
The transient transfection of Renilla and STF plasmids gave activation for several of the 
compounds, only compound C1324 and C1325 gave decreased relative luciferase to 
Renilla ratios.  
The inhibition in the screenings, hit confirmation or transfection did not seem sufficiently 
consistent to continue with further studies. The affinity and potency of the inhibitors could 
be improved by finding analogues; this was not done in this master thesis. 
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3.3 Activators 
The 33 compounds that indicated a synergistic effect on the canonical Wnt signaling 
pathway from the two screenings (see section 3.1) are summarized in Figure 20. The 
luciferase activities were calculated in % relative to positive and negative controls (see 
section 2.10 A), and the compounds with an average above 300 % were chosen for further 
examination. 
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Figure 20 Summary of potential synergists of the canonical Wnt signaling pathway from the screenings, 
Figure 14. The average of the relative luciferase activity in % (2.10 A) for the 33 compounds (two 
experiments, n=1). Bars show the average of the two screenings, error bars show the spread. 
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3.3.1 Hit confirmations and endogenous luciferase activity assays 
To confirm the results from the two screenings, the 33 compound were examined again 
with the same cells and method, but now in duplicates. 
To explore the effect of the compounds on the endogenous luciferase activity of the cells 
(i.e. the luciferase activity in the cells without activating the canonical Wnt signaling 
pathway with Wnt-3A conditioned medium), would give information about the specificity 
of the compounds. As mentioned in section 3.2.2 a compound could affect the canonical 
Wnt signaling pathway at other places than in the binding between Wnt and Frz, and it 
could also affect the luciferase reporter gene by other signaling pathways. The compound 
could influence the oxidation reaction which provides the light, or the compound could 
decrease cell growth or kill cells by binding to and disturb important cellular functions. 
The compounds could also possibly be activators of the canonical Wnt signaling pathway 
without Wnt present. Only synergists and inhibitors of the canonical Wnt signaling 
pathway that increased or decreased the binding between Wnt ligand and Frz receptor were 
sought in this study. Therefore the 33 compounds were also examined for their effect on 
the cells without Wnt ligands present. 
 
The hit confirmation experiment and the study of possible effect of the compounds on 
endogenous luciferase activity were carried out in duplicates on HEK293 STF cells. For 
the hit confirmation experiment the Wnt signaling pathway was activated with Wnt-3A 
conditioned medium, and to examine the effect of the compounds on endogenous 
luciferase activity only regular cell medium were used. In both experiments the compounds 
were added to a final concentration of 20 µM. 
Seven positive controls with Wnt-3A conditioned medium and seven negative controls 
with regular cell medium were used for the hit confirmation experiment, and the positive to 
negative ratio was 97. Eight controls with regular cell medium were used to investigate the 
effect on endogenous luciferase activity.  
The luciferase activities were measured with the Luciferase Assay System. Figure 21 
shows the luciferase activities calculated in % relative to the controls (2.10 A and B). 
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  b)                Endogenous luciferase activity assay
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Figure 21 Hit confirmation experiment and endogenous luciferase activity assay. 
a) The relative luciferase activity in % (2.10 A) for 33 compounds. Performed on HEK293 STF cells, 
activated with Wnt-3A conditioned medium, and added compounds to a final concentration of 20 µM. Bars 
show the average and error bars show the spread (n=2). Light blue colored bars indicate the compounds 
chosen for further examination. 
b) The relative luciferase activity in % (2.10 B) for 33 compounds. Performed on HEK293 STF cells with 
regular cell medium and added compounds to a final concentration of 20 µM. Bars show the average and 
error bars show the spread (n=2). Light green colored bars indicate the compounds chosen for further 
examination.  
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Many of the compounds gave relative luciferase activities below 300 % in the hit 
confirmation experiment, and only the compounds with at least one replicate value above 
350 % were chosen for further investigation (seven compounds, colored light blue in 
Figure 21a). 
Compound C1321 gave the best relative activation of the compounds, with an average 
relative luciferase activity above 800 %. This compound had a relative luciferase activity 
of ~300 % and ~900 % in the two separate screenings. 
 
From the investigation of the effect of the compounds on endogenous luciferase activity, 
two of the compounds had an average relative luciferase activity between 100 and 120 % 
and 16 of the compounds had an average between 80 and 100 %. This could be due to 
normal variation in the cells (in this master thesis the author has defined 20 % deviation 
from the control as normal variation in the endogenous luciferase activity assay). 15 of the 
compounds had an average relative luciferase activity between 60 and 80 %, and this could 
indicate non-specific or toxic effects in the cells.  
Of the seven chosen compounds from the hit confirmation experiment, three of them 
(C1129, C1321 and C1344) had an average relative luciferase activity between 60 and 80 
%. 
 
The seven chosen compounds with at least one replicate value above 350 % from the hit 
confirmation experiment were re examined in duplicates in a second hit confirmation 
experiment and endogenous luciferase activity assay. A summary of the two screenings, 
the two hit confirmation experiments and the two endogenous luciferase activity assays for 
the seven compounds are shown in Figure 22. 
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Figure 22 Summary of the screenings, hit confirmation experiments and the endogenous luciferase activity 
assays for the seven compounds that indicate a synergistic effect on HEK293 STF cells. 
a) The relative luciferase activity in % (2.10 A) of the two screenings performed on HEK293 STF cells, 
activated with Wnt-3A conditioned medium, and added compounds to a final concentration of 20 µM. Bars 
show the two screenings (two experiments with n=1). See section 3.1. 
b) The relative luciferase activity in % (2.10 A) of the two hit confirmation experiments performed on 
HEK293 STF cells, activated with Wnt-3A conditioned medium, and added compounds to a final 
concentration of 20 µM. Bars show the average and error bars show the spread (n=2). See section 3.3.1. 
c) The relative luciferase activity in % (2.10 B) in HEK293 STF cells with regular cell medium and added 
compounds to a final concentration of 20 µM. Bars show the average and error bars show the spread (n=2). 
See section 3.3.1. 
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The compounds shown in Figure 22 gave a quite similar activation in both the screening 
and the hit confirmation experiments. As mentioned earlier some variations are normal and 
due to differences in the age of the cells, where the cells are in their cycle, the age and 
strength of the Wnt-3A conditioned medium, and the stability of the compounds. But 
despite some variations, the screening and hit confirmation experiments for these 
compounds gave quite similar responses.  
Most of the compounds do not show substantial decrease in the luciferase signal when 
added to cells with regular cell medium, and this indicates little or no non-specific 
luciferase activity or toxic effect on the cells. Even though compound C1321 had a 
decreased luciferase signal of approximately 25 % in the endogenous luciferase activity 
assay, the activation found in the screening and hit confirmation experiments were so high 
that this compound was still very interesting. The specificity and toxicity of this compound 
should be examined further. 
 
3.3.2 Transfection with luciferase and Renilla plasmids 
As mentioned in section 3.2.3, the Luciferase Assay System used on HEK293 STF cells 
does not provide an internal control for normalization of the luciferase activity (but has 
other benefits, see section 3.2.3). The Dual-Luciferase Reporter Assay System, utilizing 
Renilla luciferase and firefly luciferase contain such an internal control by measuring both 
sequentially from a single sample (see section 1.7.4 and 2.7), and normalizing firefly 
luciferase activity against Renilla luciferase activity (which is a measure of the transfection 
rate and the viability of the cells).  
 
After transient transfection of Super TOP-Flash plasmids and Renilla plasmids (see section 
2.6) into HEK293 wt cells, the seven compounds were added to a final concentration of 20 
µM and the canonical Wnt signaling pathway were activated with Wnt-3A conditioned 
medium. Three positive controls with Wnt-3A conditioned medium and four negative 
controls with regular cell medium were used. The luciferase and Renilla signals were 
measured with the Dual-Luciferase Reporter Assay System (see section 2.7). The ratio 
between the luciferase signal and the Renilla signal for the compounds were normalized 
relative to the ratio between the luciferase signal and the Renilla signal for negative and 
positive controls (2.10 C), and the results are shown in Figure 23. 
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Figure 23  
a) The ratio between the luciferase activity and the Renilla activity relative to controls in % (2.10 C) for 
seven compounds (n=2) in HEK293 wt cells transient transfected with STF plasmids and Renilla plasmids, 
activated with Wnt-3A conditioned medium and added compounds to a final concentration of 20 µM. Bars 
show the average, error bars show the spread. 
b) The luciferase activity and the Renilla activity for seven compounds (n=2) in HEK293 wt cells transient 
transfected with STF plasmids and Renilla plasmids, activated with Wnt-3A conditioned medium and added 
compounds to a final concentration of 20 µM. Bars show the average, error bars show the spread. 
 
 
Compounds C1110, C1129 and C1132 did not show substantial decrease or increase in the 
activity ratio compared to the ratio of the controls. Figure 23 b shows that the luciferase 
activities actually did not increase substantially compared to positive controls for 
compound C1110, C1129 and C1132 in this experiment, but the Renilla values were 
normal for compound C1110. C1129 and C1132 had a somewhat lower Renilla signal 
compared to the rest of the compounds. This indicates that the cell vitality and the 
transfection efficiency were not the problem for C1110, but could have some small effect 
for compound C1129 and C1132. Crystal formation of the compounds could be one reason 
for these results and another reason could be the cell line. The cell line HEK293 STF is as 
mentioned clonally selected for high sensitivity. 
Compound C1104, C1109, C1321 and C1344 gave an activation compared to the controls, 
confirming the results from the screenings and hit confirmation experiments. 
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3.3.3 Specificity 
From the screenings and hit confirmation experiments compounds C1104, C1109, C1110, 
C1129, C1132, C1321 and C1344 all indicated an activating effect in the canonical Wnt 
signaling pathway by giving activation in the luciferase signaling relative to the controls. 
The endogenous luciferase activity assays showed that the compounds did not give an 
activating effect without Wnt, indicating a possibly synergistic effect. Transfection of 
luciferase and Renilla plasmids into HEK293 wt cells did not give normalized relative 
activation for compound C1110, C1129 and C1132, but they were still examined further. 
To check the specificity of the compounds for the canonical Wnt signaling pathway, they 
were further examined for their effect on the Shh signaling pathway and the NF-κB 
signaling pathway (which is also receptor activated pathways). To be used as 
pharmacological substance, the small molecule needs to be specific in targeting the 
canonical Wnt signaling pathway. The Shh signaling pathway is one of the most important 
developmental signaling pathways in the body, and NF-κB strongly controls the immune 
and inflammatory responses in the body. Therefore it is important that these signaling 
pathways are not influenced by the chosen compound. 
In addition to affecting these two signaling pathways, the effect of the compounds on the 
firefly luciferase was examined. If the compounds affect the oxidation process, e.g. by 
reacting with the luciferin directly or indirectly in some way, the relative luciferase activity 
would be increased in the Shh signaling pathway and the NF-κB signaling pathway as 
well109. 
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The Shh signaling pathway 
Two separate experiments were performed, each in duplicates. Shh-Light2 cells containing 
the integrated variant of the GLI-responsive firefly luciferase reporter gene and the Renilla 
luciferase gene which provide constitutive expression of Renilla luciferase were used. The 
compounds were added to the cells to a final concentration of 20 µM and the Shh signaling 
pathway were activated with conditioned Shh-medium (see section 2.5). Four negative 
controls with regular cell medium and four positive controls with conditioned Shh-medium 
were used. The luciferase and Renilla activity was assayed with Dual-Luciferace Reporter 
Assay System with Stop&Glo ~48 hours after adding the compounds. 
The ratio between the luciferase activity (LUC) and the Renilla activity (REN) were 
calculated relative to the ratio of the controls (see section 2.10 C), and Figure 24 shows the 
results. 
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Figure 24 The ratio between the luciferase activity and the Renilla activity relative to controls in % (2.10 C) 
for seven compounds. Shh-Light2 cells were added compounds to a final concentration of 20 µM and 
activated with conditioned Shh-medium. Bars show the average, error bars show the spread (two experiments 
with n=2). 
 
Two compounds (C1110 and C1132) had an average relative ratio between 40 and 70 %. 
This could indicate some inhibitory effect on the Shh signaling pathway or a toxic effect 
on the cells. None of compounds showed a substantial normalized relative activation, 
indicating no considerable activation in any of the pathway components of the Shh 
signaling pathway. 
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The NF-κB signaling pathway 
Two separate experiments were performed, each in duplicates. HEK293 wt cells were 
transiently transfected with NF-κB-luc plasmids and Renilla plasmids (see section 2.6). 
After 18 hours the compounds were added to a final concentration of 20 µM and the NF-
κB signaling pathway were activated with TNF-α medium. Four negative controls with 
regular cell medium and four positive controls with TNF-α medium were used. The 
luciferase and Renilla activity was assayed with Dual-Luciferace Reporter Assay System 
with Stop&Glo ~24 hours after adding the compounds. 
The ratio between the luciferase activity (LUC) and the Renilla activity (REN) were 
calculated relative to the ratio of the controls (see section 2.10 C), and Figure 25 shows the 
results. 
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Figure 25 The ratio between the luciferase activity and the Renilla activity relative to controls in % (2.10 C) 
for seven compounds. HEK293 wt cells were added compounds to a final concentration of 20 µM and the 
signaling pathway were activated with TNF-α medium. Bars show the average, error bars show the spread 
(two experiments with n=2). 
 
None of the compounds showed substantial increase or decrease in the ratio compared to 
controls, which indicates that the compounds did not have any considerable effect on any 
of the pathway components in the NF-κB signaling pathway. 
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3.3.4 Examination of compound concentration 
The seven chosen compounds gave increased relative activation compared to controls 
when tested on HEK293 STF cells, but some of them indicated a non-specific or toxic 
effect by giving a decreased luciferase to Renilla ratio in the transfection (section 3.3.2) 
and when tested on the Shh signaling pathway (section 3.3.3). High concentration of 
compounds could be the reason for the possibly toxic effect; therefore different 
concentrations of the compounds were investigated. If a compound gave high relative 
activation at low concentrations, this could indicate specific and high affinity for the 
binding between Wnt and Frizzled.  
 
To explore the effect of different concentrations of a compound on the HEK293 STF cells 
with Wnt-3A conditioned medium, four different concentrations were used (final 
concentration of 0.5, 1, 5, 10 and 20 µM). Eight positive controls with Wnt-3A conditioned 
medium and eight negative controls with regular cell medium were used. The luciferase 
activities were measured with the Luciferase Assay System. The positive to negative ratio 
was 154 (see section 2.10 D). Figure 26 shows the results calculated relative to positive 
and negative controls (see section 2.10 A). 
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Figure 26 The relative luciferase activity in % (2.10 A) for seven compounds. Performed on HEK293 STF 
cells, activated with Wnt-3A conditioned medium, and added compounds to a final concentration of 0.5, 1, 5, 
10 and 20 µM. The trend lines are drawn between average values and error bars show the spread (n=2).  
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The activation of the luciferase signals was less than in the screening and hit confirmation 
experiments, but still a small or in average increase in the signal was observed. As a 
general trend, the signal increased from 0.5 to 10 µM for all the compounds, but with a 
decrease in signal for 20 µM. The lower signal for 20 µM compared to 10 µM could be 
explained by a toxic effect of the compounds on the cells. 
Compound C1321 again gave the highest relative activation at all concentrations, reflecting 
its potency in promoting binding of Wnt-3A to Frz. 
 
3.3.5 Concluding remarks  
From the 33 possible activators chosen from the two screening experiments, with an 
average above 300 % relative to positive and negative controls, seven compounds gave at 
least one measurement above 350 % in the first hit confirmation experiment and were 
selected for further examination. The second hit confirmation experiment also gave good 
increased luciferase activity, and the toxicity of the compounds did not seem to be 
considerable. 
By using transfection of Renilla and luciferase plasmids activation in the Renilla to 
luciferase ratio was found for C1104, C1109, C1321 and C1344, but not for C1110, C1129 
and C1132. 
The specificity of the compounds for the canonical Wnt signaling pathway seemed to be 
very good. C1110 and C1132 appeared to inhibit the Shh signaling pathway to some 
extent, but none of the compounds gave activation compared to the controls. The ratio 
between luciferase and Renilla when the compounds were investigated for effect on the 
NF-κB signaling pathway did not indicate activation or inhibition. 
Increased concentration, up to 10 µM final concentrations of the compounds, gave an 
increased activation of luciferase signaling. The decrease in activation for 20 µM 
compound can be explained by non-specific or toxic effects on the cells. 
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3.4 Compound analogues – screening, hit confirmation 
experiment and endogenous luciferase activity assay 
 
The seven compounds that gave increased activation in the luciferase signal when added to 
HEK293 STF cells with Wnt-3A conditioned medium were used for further modeling and 
analogue development by Andrew Voronkov, who suggested 226 analogue compounds.  
 
The analogue development was performed to find compounds that gave even higher 
activation at lower concentrations (higher specificity and better binding properties) would 
increase the potency. From the experimental data resulting in finding the seven 
compounds, the in silico modeling was adjusted and analogues which in theory could 
increase the binding between Wnt and Frizzled even more were found. 
 
The screening of these 226 new compounds was done once in duplicates. HEK293 STF 
cells were added compounds to a final concentration of 20 µM, and the canonical Wnt 
signaling pathway was activated with Wnt-3A conditioned medium. Four negative controls 
with regular cell medium and four positive controls with Wnt-3A conditioned medium 
were used. The luciferase activity was measured with the Luciferace Assay System, and 
the luciferase values were calculated relative to the average of the controls (2.10 A). The 
positive to negative ratio was 50 (2.10 D). 
Figure 27 shows the 226 compounds sorted by average relative luciferase activation. 
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Figure 27 The relative luciferase activity in % (2.10 A) for 226 compounds in HEK293 STF cells, activated 
with Wnt-3A conditioned medium, and added compounds to a final concentration of 20 µM. Bars show the 
average and error bars show the spread (n=2). Light red and light blue colored bars indicate the compounds 
chosen for further examination. 
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Some of the compounds gave a decreased relative luciferase signal, and the one with the 
lowest signal (C1399) was chosen for further examination. The twelve compounds that 
gave the highest average relative luciferase activation were also chosen for further 
investigation. 
 
The chemotypes for the seven compounds from the first screening experiments (C1104, 
C1109, C1110, C1129, C1132, C1321 and C1344) and of the thirteen compounds from the 
second screening experiment (C1410, C1428, C1434, C1436, C1466, C1468, C1485, 
C1505, C1543, C1545) was revealed to the author. Compound C1104, C1109 and C1110 
belong to the same chemotype, and C1109 and C1110 are quite similar. Compound C1399 
belong to the same chemotype as C1321, as do also 11 of the compounds that gave the best 
activation. C1539 was actually revealed to be the same compound as C1321. Compound 
C1375 belong to the same chemotype as C1132. 
The structures of the seven compounds from the first screening (C1104, C1109, C1110, 
C1129, C1132, C1321 and C1344) and of the ten compounds similar to C1321/C1539 
(C1410, C1428, C1434, C1436, C1466, C1468, C1485, C1505,  C1543, C1545) were 
revealed to the author, but can not be revealed in this thesis. 
 
To confirm the screening results and to compare the new compounds to the former 
compounds, the twenty compounds were re-examined in duplicates. HEK293 STF cells 
were added compounds to a final concentration of 20 µM, and the canonical Wnt signaling 
pathway was activated with Wnt-3A conditioned medium. Four negative controls with 
regular cell medium and four positive controls with Wnt-3A conditioned medium were 
used. The luciferase activities were measured with the Luciferase Assay System. The 
positive to negative ratio was 35 (2.10 D). 
 
The effects of the 20 compounds on endogenous luciferase activity were also examined in 
duplicates. HEK293 STF cells were added regular cell medium and compounds to a final 
concentration of 20 µM. Four controls with regular cell medium were used, and the 
Luciferase Assay System was used to measure the activation.  
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Figure 28 shows the results from the hit confirmation experiment and the endogenous 
luciferase activity assay, sorted by chemotype of the compounds (light blue and light green 
bars point out the compounds included from the second modeling experiment). 
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  b)                Endogenous luciferase activity assay
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Figure 28 Hit confirmation experiment and endogenous luciferase activity assay of seven compounds from 
the first screenings and 13 compounds from the last screening, sorted by chemotypes. 
a) The relative luciferase activity in % (2.10 A) for 20 compounds in HEK293 STF cells, activated with Wnt-
3A conditioned medium, and added compounds to a final concentration of 20 µM. Bars show the average and 
error bars show the spread (n=2). Light blue colored bars indicate the compounds included from the second 
modeling experiment. 
b) The relative luciferase activity in % (2.10 B) for 20 compounds in HEK293 STF cells with regular cell 
medium and added compounds to a final concentration of 20 µM. Bars show the average and error bars show 
the spread (n=2). Light green colored bars indicate the compounds included from the second modeling 
experiment. 
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A compound that gave an inhibition of the luciferase signal (C1399) showed quite a toxic 
or non-specific effect on the cells (relative activation ~50 %), and was not chosen for 
further studies. The best activators were all from the same chemotype as C1321, and even 
though they gave quite a relative reduction in the luciferase signal without Wnt-3A 
conditioned medium (endogenous luciferase activity assay) they were still chosen for 
further examination. 
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3.5 C1321 and analogues 
To investigate the effect of different concentrations of compounds (see section 3.3.4), 
C1321/C1539 and the ten compounds with the same chemotype were examined twice in 
duplicates. HEK293 STF cells were added compounds to a final concentration of 1, 5, 10 
and 20 µM and the canonical Wnt signaling pathway was activated with Wnt-3A 
conditioned medium. Four positive controls with Wnt-3A conditioned medium and four 
negative controls with regular cell medium were used, and the positive to negative ratio 
were approximately 20 in the first experiment and approximately 35 in the second 
experiment (2.10 D). The luciferase activities were measured with the Luciferase Assay 
System, and the values were calculated relative to positive and negative controls. Figure 29 
shows the results from this examination of concentration dependency. 
For all the compounds, the luciferase signal increased with increasing compound 
concentration. For some of the compounds the luciferase signal decreased a little from 10 
µM to 20 µM, and this could be due to a toxic reaction or non-specific binding because of 
high concentration. 
Compounds C1321 and C1539 is the same compound, but C1539 gave a somewhat higher 
luciferase signal in the first experiment. In the second experiment the signals were 
generally lower, and this could among other be due to the stability of the compound. The 
concentration of the Wnt-3A conditioned medium could also have affected the signal level. 
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Figure 29 The relative luciferase activity in % (2.10 A) for 12 compounds in HEK293 STF cells, activated 
with Wnt-3A conditioned medium, and added compounds to a final concentration of 1, 5, 10 and 20 µM. 
Bars show the average and error bars show the spread (n=2). 
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3.6 C1321 
3.6.1 Further examination of concentration dependency 
To investigate the effect of different concentrations of the Wnt-3A conditioned medium 
together with different concentrations of compound C1321, HEK293 STF cells were 
activated with different concentrations of Wnt-3A conditioned medium and compound. 
Two experiments were set up with final concentration of compound C1321 of 1, 5, 10 and 
20 µM, in duplicates. One experiment was set up with final concentration of 5, 10, 20 and 
40 µM, also in duplicates. All three experiments had four negative controls with regular 
cell medium and three positive controls for each medium concentration of Wnt-3A 
conditioned medium. The positive to negative ratios varied from 2 to almost 600, which is 
a measure of the strength of the medium (see Figure 30). 
 
Figure 30 The relative luciferase activity in % (2.10 A) for different concentrations of compound C1321 in 
HEK293 STF cells activated with Wnt-3A conditioned medium at different concentrations. The trend lines 
are drawn between average values and error bars show the spread (n=2). 
a) Two experiments with added compound to a final concentration of 1, 5, 10 and 20 µM.  
b) One experiment with added compound to a final concentration of 5, 10, 20 and 40 µM. 
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Increased concentration of compound gave an increased luciferase signal for all of the 
different medium concentrations, however with a slight decrease for 40 µM of compound 
with medium with a positive to negative ratio of 109, which was possibly due to toxic or 
non-specific effects on the cells. A very high positive to negative ratio (strong Wnt-3A 
conditioned medium) generally gave less luciferase activity compared to more moderate 
positive to negative ratios. A medium to low positive to negative ratio gave the best 
luciferase activity, but the luciferase activities varied a lot between the experiments. The 
varying relative luciferase activity due to varying strength of Wnt-3A conditioned medium 
could possibly explain some of the variation in relative activity seen for the other 
compounds as well. 
 
3.6.2 Real-time RT-PCR 
Activation of the canonical Wnt signaling pathway will give an increased concentration of 
β-catenin, which will translocate into the nucleus. After the β-catenin enters the nucleus it 
functions as a temporary framework to bind TCF/LEF-family transcription factors to the 
Wnt target genes and trigger a transcription of these genes (see Figure 2). 
With pSTF transfected as a plasmid, or stably transfected into the cell line, the luciferase 
signal will be activated through 7xTCF binding sites (see section 1.7.5).  
Axin2 is a well described110 target gene and its transcript is promoted by activated Wnt 
signaling111, 112, 113. In RT-PCR Axin2 could be used to quantify the activation of the 
canonical Wnt signaling pathway. GAPDH (glyceraldehyde-3-phosphate dehydrogenase) 
is a gene that is constitutively expressed in the cells, often referred to be a housekeeping 
gene107, 114, and is often used as an internal control in RT-PCR. A housekeeping gene is 
generally a constitutive gene which is found in most cells and that controls basic cellular 
functions, and that give constant expression115.  
 
HEK293 wt cells were plated in a 12 wp coated with poly-L-lysine and the cells were 
grown overnight. Different concentrations of Wnt-3A conditioned medium were used to 
activate the canonical Wnt signaling pathway, and C1321 was added to a final 
concentration of 5, 10 and 20 µM. Four replicates were performed, and four positive and 
four negative controls were used.  
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A real-time RT-PCR with primers for Axin2 and GADPH was performed with standard 
protocols (see section 2.8), and MxPro QPCR Software from Stratagene was used for 
calculations. 
Figure 31 shows a general increase in activation when C1321 was added, compared to 
positive and negative controls. 
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Figure 31 The normalized relative quantity of Axin2 mRNA for compound C1321 in HEK293 wt cells 
activated with Wnt-3A conditioned medium (20, 50 and 100 %) and added compounds to a final 
concentration of 5, 10 and 20 µM. Bars show the average and error bars show the standard deviation (n=4). 
 
Figure 31 shows that compound C1321, in a dose dependent manner, is capable of 
promoting transcription of the canonical Wnt signaling pathway target gene Axin2. This is 
consistent with the experiments done on HEK293 STF cells with the Luciferase Assay 
System. 
20 % Wnt-3A conditioned medium obtained a somewhat but not substantially higher 
quantity of Axin2 mRNA than with 50 % and 100 % Wnt-3A conditioned medium. 
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4 Final discussion and conclusion 
 
Andrew Voronkov suggested 256 small molecules in an in silico based screening to be 
potential modulators of the Wnt/Frizzled (CRD) interaction. By modulating this 
interaction, we wanted to increase or decrease the canonical Wnt signaling activity. These 
256 compounds were investigated, in a small based screening experiment, against a 
luciferase based reporter system in the Wnt-3A responsive cell line HEK293 STF. 
Twelve potential inhibitors and 33 activators (synergists) were found based on defined 
threshold levels. The inhibiting activities of three compounds (C1270, C1290 and C1336) 
were confirmed by a second experiment setup. However, these three compounds also 
affected endogenous luciferase activity and only a minor signal reduction was obtained 
when a Renilla internal reporter was used in parallel. As the potency of the inhibitors was 
ineffectual, when compared to previously published inhibitors73, 75, no further efforts in 
development of the chemotypes were pursued. Seven of the 33 activators (C1104, C1109, 
C1110, C1129, C1132, C1321 and C1344) were likewise chosen for further investigation 
based on the activating capacity in a second experiment. No substantial decrease of the 
endogenous luciferase activity was detected after exposure by these seven compounds on 
HEF293 STF cells. The seven compounds did not activate the pathway without Wnt-3A 
present in the cell culture medium. This indicates that the compounds affect the activity of 
canonical Wnt pathway only when the Wnt/Frizzled (CRD) complex is formed. An 
enhanced complex interaction, promoted by the compounds, may therefore be suggested. 
The specific effect on the Wnt/Frizzled interaction was supported as none of the seven lead 
compounds could activate or synergize the activity of Shh- or NF-κB luciferase reporters, 
which are both pathways that also are activated by ligand to receptor binding.  
To further develop the potency in synergizing the canonical Wnt signaling pathway, and 
the affinity against the Wnt/Frizzled complex, 226 analogues based on the seven lead 
compounds were suggested by Andrew Voronkov. No enhanced activating properties 
could be detected among these analogues when compared to their originating chemotypes. 
Compound C1321 was identified to be the compound with strongest capacity in 
synergizing the canonical Wnt signaling pathway in HEK293 STF cells. The specific 
activity of compound C1321 was further confirmed by real-time RT-PCR measurement of 
the Wnt target gene Axin2.  
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Collaboration with Dietmar Gradl (University of Karlsruhe) showed that compound C1321 
had a similar synergizing effect on development of a second body axis after co-injection in 
a Xenopus axis duplication assay (data not shown). A second body axis is formed in 
Xenopus when XWnt8 is injected into the ventral blastomeres of a four-cell stage 
embryo116.  
Taken together, the compound C1321 activity on HEK293 STF reporter activity, Axin2 
real-time RT-PCR and Xenopus axis duplication indicate the promising potential in 
modulating the canonical Wnt signaling pathway at the receptor level. Compound C1321 
has a stronger synergizing effect in the STF assay when compared to the previously 
published compound QS1171. The stability and the target affinity may be further developed 
by suggesting new analogues to enhance the C1321 synergy efficacy. Compound C1321 
should also be examined against other cell lines and especially against stem cells (adult and 
embryonic) and cells from the neuronal lineage. If efficacy is shown against stem cells or 
neuronal cells, compound C1321 may have potential in controlling stem cell 
differentiation117 and protect against Alzheimers disease17. 
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Attachments 
Attachment 1: Recipes 
PBS: 
137 mM NaCl, 10 mM Phosphate, 2.7 mM KCl, PH 7,4 
- Dissolve in 800 mL of distilled H2O 
- 8 g NaCl 
- 0.2 g KCl 
- 1.44 g Na2HPO4 
- 0.24 g KH2PO4 
- Adjust the pH to 7.4 with HCl 
- Add H2O to 1 L 
- Sterilized by autoclaving (20 min, 121 °C, liquid cycle) 
- Stored at room temperature 
 
TE buffer: 
- 10 mM Tris 
- Adjust to pH 7.5 with HCl 
- 1mM EDTA 
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